US News

U.S. Boosts Order for Glaxo's Covid-19 Antibody Drug

The government agreed to buy more doses of an antibody drug for the early treatment of Covid-19 developed by GlaxoSmithKline and Vir Biotechnology, bringing its total order to nearly $1 billion.

Jump To The Original Source

Facebook Comments

Check Also

Australia’s reopening plans in doubt after Omicron cases

Published by Reuters By Renju Jose SYDNEY (Reuters) ...

Archives